Genetic Mapping of Atherogenic Lipoprotein Phenotypes

NCT00005465 · Status: COMPLETED · Type: OBSERVATIONAL

Last updated 2016-02-10

No results posted yet for this study

Summary

To map the major gene influencing low-density lipoprotein subclass phenotypes, denoted atherogenic lipoprotein (ALP) phenotypes, with a long term goal of cloning the ALP gene and understanding its role in genetic susceptibility to atherosclerosis.

Conditions

Sponsors & Collaborators

Eligibility

Max Age
100 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
1991-08-31
Completion
1996-07-31

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00005465 on ClinicalTrials.gov